Business Wire
Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
➖
AI Sentiment
Neutral
5/10
Verastem Inc. News
Latest updates and market news for VSTM
3 news
Feb 15 - Feb 21, 2026
Page 1
MarketBeat
Verastem Touts 50%+ Sales Growth for LGSOC Launch, Teases RAMP 301 and KRAS G12D Catalysts
📈
AI Sentiment
Highly Positive
9/10
Share this news page